Menu

Image of the Day: Distress Signal

Dolphins and pilot whales can tell which orcas are coming for them by listening to their calls.  

Jun 13, 2018
Sukanya Charuchandra

A killer whale call is played 10 seconds into the recording, when a pilot whale responds by vigorously moving (splashing sounds). RESEARCH AND PHOTO COLLECTED UNDER NMFS PERMIT BY ARI FRIEDLAENDER. AUDIO BY MATTHEW BOWERS. 

Not all orcas eat ocean-going mammals, such as dolphins and seals. Some favor fish. Research published in the Journal of Experimental Biology on June 12 puts forward evidence that dolphins and pilot whales can distinguish between the calls of predatory killer whales and those that refrain from eating aquatic mammals.

A group of Risso’s dolphins off the coast of southern California. One dolphin is carrying a multi-sensor acoustic recording tag that is used to measure the response of the dolphins to sounds of their predators. RESEARCH AND PHOTO COLLECTED UNDER NMFS PERMIT BY ARI FRIEDLAENDER.

The scientists attached a data-logger to one member of each pod of dolphins and pilot whales to record their responses to killer whale calls played to them. Four particular calls by killer whales elicited a strong reaction from the pods. While pilot whales were drawn to those calls, the dolphins raced away.

Surprisingly, the predatory killer whale calls were structured similar to human and other mammalian distress sounds.

“We suggest that these calls convey information about the predators’ behavior or intent,” Matthew Bowers, a coauthor on the study, says in a statement.  

M.T. Bowers et al., “Selective reactions to different killer whale call categories in two delphinid species,” J Exp Biol, doi:10.1242/ jeb.162479, 2018.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.